NCT01065441 2020-01-22
Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer
Mirror Biologics, Inc.
Phase 1/2 Completed
Mirror Biologics, Inc.
Fuda Cancer Hospital, Guangzhou
Fuda Cancer Hospital, Guangzhou
Columbia University